Dermatan Sulfate

desmin ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 11050699 Pharmacodynamic study of low molecular weight dermatan sulphate (Desmin) after a single subcutaneous administration in patients with renal insufficiency. 2000 Sep 1
2 9626917 Desmin (a low molecular weight dermatan sulphate) versus heparin in the treatment of patients with deep venous thrombosis. 1998 Apr 2
3 9684733 Pharmacokinetics of low molecular weight dermatan sulphate (desmin) in different cohorts of patients. 1998 May 1 1
4 9100165 Efficacy of an intravenous low-molecular-weight dermatan sulphate (Desmin) in patients with acute proximal deep venous thrombosis and silent pulmonary embolism. A pilot study. 1997 Mar-Apr 1
5 9352383 Bioavailability of Desmin, a low molecular weight dermatan sulfate, after subcutaneous administration to healthy volunteers. 1997 2
6 8810655 Tolerability and clinical efficacy of desmin in the treatment of superficial thrombovaricophlebitis. 1996 Sep 1
7 8815578 Low molecular weight heparin is responsible for the anti-Xa activity of Desmin 370. 1996 Feb 1
8 8837309 Pharmacology of a new low molecular weight dermatan sulphate (Desmin) in healthy volunteers: repeated daily intramuscular administration of 400 mg for a week. 1996 Jul 1 1
9 8845462 Effects of low-molecular-weight dermatan sulfate on coagulation, fibrinolysis and tissue factor pathway inhibitor in healthy volunteers. 1996 Jan 2
10 8533121 Pharmacology of desmin (low molecular weight dermatan sulphate) in healthy volunteers following intravenous bolus administration of different dosages (200, 400, 800 mg). 1995 Aug 1 2
11 7824960 Pharmacological activity of a low molecular weight dermatan sulfate (desmin) in healthy volunteers. 1994 1